Operating Grant: TRANSCAN-3
Canadian Institutes of Health Research (CIHR)
In the last decades the understanding of the molecular mechanisms responsible for cancer development and progression has significantly improved. In particular, a lot of progress has been made regarding the genetics of cancer that has led to the discovery and implementation into the clinic of numerous treatments as well as many biomarkers to improve screening, diagnosis and prognosis of cancers ,leading to an increase in survival and improvement in the quality of life of cancer patients.
Considering this background, the TRANSCAN-3 partners have agreed to focus their third Joint Transnational Call for proposals (JTC 2023) on: "Translational research on cancer epigenetics". TRANSCAN-3 aims at promoting highly innovative and ambitious collaborative projects in translational cancer research at European and international level.
The maximum amount per grant is $450,000 for three years.
Notice of Decision on Pre-Proposal: October 27, 2023
Anticipated Notice of Decision: April 30, 2024
Funding Start Date: September 1, 2024
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Pre-Application |
| 21-Jul-2023 |
Application (Upon Invitation Only) | 06-Dec-2023 4:30 pm CST | 15-Dec-2023 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.